loading
Canopy Growth Corporation stock is traded at $1.27, with a volume of 16.91M. It is up +2.42% in the last 24 hours and up +1.60% over the past month. Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See More
Previous Close:
$1.24
Open:
$1.25
24h Volume:
16.91M
Relative Volume:
1.28
Market Cap:
$304.61M
Revenue:
$211.87M
Net Income/Loss:
$-551.61M
P/E Ratio:
-0.1861
EPS:
-6.8241
Net Cash Flow:
$-140.45M
1W Performance:
-2.31%
1M Performance:
+1.60%
6M Performance:
-22.09%
1Y Performance:
-79.32%
1-Day Range:
Value
$1.21
$1.31
1-Week Range:
Value
$1.15
$1.46
52-Week Range:
Value
$0.77
$6.30

Canopy Growth Corporation Stock (CGC) Company Profile

Name
Name
Canopy Growth Corporation
Name
Phone
855-558-9333
Name
Address
1 Hershey Drive, Smiths Falls, ON
Name
Employee
2,000
Name
Twitter
@CanopyGrowth
Name
Next Earnings Date
2025-08-08
Name
Latest SEC Filings
Name
CGC's Discussions on Twitter

Compare CGC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
CGC
Canopy Growth Corporation
1.27 328.59M 211.87M -551.61M -140.45M -6.8241
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
156.62 67.51B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.52 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.82 43.42B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.46 20.72B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
312.23 14.21B 2.99B 1.21B 1.13B 25.06

Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-04-23 Upgrade Bernstein Underperform → Mkt Perform
Nov-02-22 Initiated Bernstein Underperform
Oct-26-22 Upgrade Canaccord Genuity Sell → Hold
Jun-08-22 Downgrade BMO Capital Markets Market Perform → Underperform
Mar-22-22 Downgrade Barclays Equal Weight → Underweight
Dec-22-21 Downgrade BofA Securities Neutral → Underperform
Dec-20-21 Downgrade Piper Sandler Neutral → Underweight
Dec-07-21 Initiated Wells Fargo Underweight
Nov-18-21 Initiated Barclays Equal Weight
Nov-08-21 Downgrade CIBC Neutral → Sector Underperform
Nov-08-21 Downgrade Canaccord Genuity Hold → Sell
Nov-08-21 Downgrade Cowen Outperform → Market Perform
Oct-01-21 Downgrade BofA Securities Buy → Neutral
Aug-12-21 Upgrade Jefferies Underperform → Hold
Jun-02-21 Upgrade Canaccord Genuity Sell → Hold
May-25-21 Upgrade MKM Partners Neutral → Buy
Apr-28-21 Resumed BofA Securities Buy
Feb-24-21 Downgrade Jefferies Hold → Underperform
Feb-10-21 Downgrade Canaccord Genuity Hold → Sell
Feb-10-21 Downgrade The Benchmark Company Buy → Hold
Feb-05-21 Downgrade Piper Sandler Overweight → Neutral
Sep-04-20 Upgrade CFRA Buy → Strong Buy
Jun-01-20 Downgrade BMO Capital Markets Outperform → Market Perform
Jun-01-20 Downgrade Bryan Garnier Neutral → Sell
Jun-01-20 Downgrade CIBC Sector Outperform → Neutral
Jun-01-20 Downgrade Ladenburg Thalmann Buy → Neutral
Jun-01-20 Downgrade Stifel Buy → Sell
May-22-20 Resumed BofA/Merrill Buy
Apr-16-20 Upgrade Jefferies Underperform → Hold
Jan-28-20 Upgrade BMO Capital Markets Market Perform → Outperform
Dec-12-19 Reiterated Cantor Fitzgerald Neutral
Nov-20-19 Upgrade BofA/Merrill Neutral → Buy
Nov-15-19 Downgrade Alliance Global Partners Buy → Neutral
Nov-05-19 Initiated Cantor Fitzgerald Neutral
Oct-14-19 Downgrade Seaport Global Securities Buy → Neutral
Oct-11-19 Downgrade Jefferies Hold → Underperform
Sep-27-19 Downgrade BofA/Merrill Buy → Neutral
Sep-20-19 Initiated MKM Partners Neutral
Sep-18-19 Initiated Oppenheimer Perform
Aug-26-19 Upgrade Seaport Global Securities Neutral → Buy
Jul-17-19 Initiated Ladenburg Thalmann Buy
View All

Canopy Growth Corporation Stock (CGC) Latest News

pulisher
Aug 20, 2025

Cannabis Stocks To Follow TodayAugust 19th - MarketBeat

Aug 20, 2025
pulisher
Aug 19, 2025

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors - ca.finance.yahoo.com

Aug 19, 2025
pulisher
Aug 19, 2025

Canopy Growth Corporation Struggles With Losses Amidst Financial Challenge - timothysykes.com

Aug 19, 2025
pulisher
Aug 18, 2025

Canopy Growth Corporation (CGC) Growth Accelerates U.S. Expansion with Major Acquisitions - MSN

Aug 18, 2025
pulisher
Aug 18, 2025

Canopy Growth Corporation’s Beta Climbs After Market VolatilityJuly 2025 PreEarnings & Breakout Confirmation Alerts - newsimpact.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

Promising Cannabis Stocks To Add to Your WatchlistAugust 17th - MarketBeat

Aug 18, 2025
pulisher
Aug 18, 2025

Canopy USA appoints Casey Rash as chief financial officer - MarketScreener

Aug 18, 2025
pulisher
Aug 18, 2025

Canopy Growth appoints new executive team - TipRanks

Aug 18, 2025
pulisher
Aug 18, 2025

Canopy USA names new executive team for expansion - StreetInsider

Aug 18, 2025
pulisher
Aug 18, 2025

Major Cannabis Leadership Shake-Up: Canopy USA Builds All-Star Executive Team for National Expansion - Stock Titan

Aug 18, 2025
pulisher
Aug 17, 2025

Canopy Growth Urges Shareholders to Vote in Upcoming Meeting - MSN

Aug 17, 2025
pulisher
Aug 17, 2025

Canopy Growth Corporation Faces Volatility Amid Earnings Concerns - timothysykes.com

Aug 17, 2025
pulisher
Aug 17, 2025

Published on: 2025-08-17 13:46:32 - sundaytimes.kr

Aug 17, 2025
pulisher
Aug 16, 2025

U.S. federal cannabis rescheduling: A game-changer for Canopy Growth? - MSN

Aug 16, 2025
pulisher
Aug 16, 2025

Published on: 2025-08-17 09:48:24 - mustnews.co.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Best Cannabis Stocks To Follow TodayAugust 15th - MarketBeat

Aug 16, 2025
pulisher
Aug 15, 2025

Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending Stock - MSN

Aug 15, 2025
pulisher
Aug 15, 2025

Im Cannabis Corp. shares rise 1.13% intraday after Canopy Growth announced its 2025 annual general and special meeting of shareholders. - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Unexpected Surge: Canopy Growth Corporation Analysis - StocksToTrade

Aug 15, 2025
pulisher
Aug 15, 2025

New Bill: Representative W. Gregory Steube introduces H.R. 4963: Marijuana 1-to-3 Act of 2025 - Quiver Quantitative

Aug 15, 2025
pulisher
Aug 15, 2025

Can Canopy Growth Corporation disrupt its industryPortfolio Performance Report & AI Powered Buy and Sell Recommendations - classian.co.kr

Aug 15, 2025
pulisher
Aug 15, 2025

Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now - MarketScreener

Aug 15, 2025
pulisher
Aug 15, 2025

Critical 33.3% Quorum Needed: Canopy Growth's Annual Meeting Includes Reverse Stock Split Vote - Stock Titan

Aug 15, 2025
pulisher
Aug 15, 2025

Canopy Growth Corporation shares rise 5.37% premarket after Invivyd's FDA alignment on rapid pathway for COVID-19 vaccine alternative. - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

U.S. federal cannabis rescheduling: A game-changer for Canopy Growth? | 2025-08-15 | Investing News - Stockhouse

Aug 15, 2025
pulisher
Aug 14, 2025

Options Data Show Bullish Bias in Canopy Growth CorporationDollar Strength & Fast Moving Stock Watchlists - newsyoung.net

Aug 14, 2025
pulisher
Aug 14, 2025

In-Depth Analysis of Canopy Growth Corporation’s Financial Landscape - StocksToTrade

Aug 14, 2025
pulisher
Aug 13, 2025

Canopy Growth’s Earnings Call: Mixed Sentiments and Strategic Moves - The Globe and Mail

Aug 13, 2025
pulisher
Aug 13, 2025

Canopy Growth: Soaring or Sinking? - timothysykes.com

Aug 13, 2025
pulisher
Aug 13, 2025

Canopy Growth Corporation shares rise 2.44% after-hours following Hilton's announcement of Canopy by Hilton Makati opening in 2026. - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Canopy Growth Stock Surge: Timing for Buying? - StocksToTrade

Aug 13, 2025
pulisher
Aug 13, 2025

CGC Stock: Unexpected Surge, Buying Opportunity? - timothysykes.com

Aug 13, 2025
pulisher
Aug 13, 2025

Canopy Growth reports higher cannabis sales but posts multi-million dollar loss - Lanarkleedstoday.ca

Aug 13, 2025
pulisher
Aug 12, 2025

Cannabis ETFs Light Up As Trump Eyes Marijuana Reclassification - Benzinga

Aug 12, 2025
pulisher
Aug 12, 2025

Does Canopy Growth Corporation have declining or rising EPSHigh Octane Equity Watchlist - thegnnews.com

Aug 12, 2025
pulisher
Aug 12, 2025

Promising Cannabis Stocks To Keep An Eye OnAugust 12th - MarketBeat

Aug 12, 2025
pulisher
Aug 12, 2025

Cannabis MSOs cool after rally driven by rescheduling hopes - Seeking Alpha

Aug 12, 2025
pulisher
Aug 12, 2025

Explainer: How US marijuana reclassification could help cannabis companies - Reuters

Aug 12, 2025
pulisher
Aug 12, 2025

Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification - Yahoo Finance

Aug 12, 2025
pulisher
Aug 12, 2025

Canopy Growth launches 7ACRES in Australia - MMJDaily

Aug 12, 2025
pulisher
Aug 12, 2025

The Canopy, TerrAscend, and Village Farms Earnings Breakdown - The Dales Report

Aug 12, 2025
pulisher
Aug 12, 2025

Canopy Growth Corporation (NASDAQ:CGC) Q1 2026 Earnings Call Transcript - Insider Monkey

Aug 12, 2025
pulisher
Aug 12, 2025

Canopy Growth, Silver North Resources, Vonovia – Clear signals | 2025-08-12 | Investing News - Stockhouse

Aug 12, 2025
pulisher
Aug 12, 2025

Canopy Growth shares surge 13.92% in premarket after Trump considers reclassifying cannabis and company reports strong Q1 earnings. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Canopy Growth Soars 12.03% on Trump's Marijuana Rescheduling Consideration - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Tilray Surges 14% After Hours On Trump Cannabis Reclassification - Benzinga

Aug 12, 2025
pulisher
Aug 11, 2025

Cronos Rallies Amidst Greater Cannabis Sector Rally Over Possible Rescheduling (CRON) - Seeking Alpha

Aug 11, 2025
pulisher
Aug 11, 2025

Canopy Growth Q1 Revenue Jumps on Strong Cannabis Sales - Tobacco Reporter

Aug 11, 2025
pulisher
Aug 11, 2025

Canopy Growth Rallies On News Of Possible Rescheduling From Trump - Seeking Alpha

Aug 11, 2025
pulisher
Aug 11, 2025

Pot Stocks Soar As Trump Considers Drug Reclassification - FA Mag

Aug 11, 2025
pulisher
Aug 11, 2025

Cannabis stocks spike as Trump signals possible reclassification - The Globe and Mail

Aug 11, 2025

Canopy Growth Corporation Stock (CGC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Canopy Growth Corporation Stock (CGC) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Kruh Willy
Director
Jun 30 '25
Sale
1.23
10,468
12,876
73,390
Lazzarato David Angelo
Director
Jun 30 '25
Sale
1.23
15,701
19,312
119,064
Hong Judy Eun Joo
Chief Financial Officer
Jun 16 '25
Sale
1.63
38,678
62,866
579,889
Gedeon Christelle
See Remarks
Jun 16 '25
Sale
1.47
9,555
14,046
389,945
Yanofsky Theresa
Director
Mar 31 '25
Sale
0.92
2,004
1,844
20,199
Lazzarato David Angelo
Director
Mar 31 '25
Sale
0.92
3,004
2,764
22,886
Kruh Willy
Director
Mar 31 '25
Sale
0.92
2,012
1,851
9,272
Kruh Willy
Director
Dec 31 '24
Sale
2.67
2,004
5,351
11,284
Yanofsky Theresa
Director
Dec 31 '24
Sale
2.67
1,996
5,329
22,203
Mongeau Luc
Director
Dec 31 '24
Sale
2.67
2,004
5,351
11,277
$29.75
price up icon 2.37%
$17.91
price up icon 2.40%
drug_manufacturers_specialty_generic RDY
$14.51
price up icon 0.62%
$10.65
price down icon 0.37%
$135.43
price up icon 0.11%
$312.23
price up icon 0.51%
Cap:     |  Volume (24h):